tradingkey.logo

Mira Pharmaceuticals Announces New Study Results For SKNY-1 - SEC Filing

ReutersJun 30, 2025 11:38 AM

- Mira Pharmaceuticals Inc MIRA.O:

  • MIRA PHARMACEUTICALS INC - ANNOUNCES NEW STUDY RESULTS FOR SKNY-1 - SEC FILING

  • MIRA PHARMACEUTICALS INC - IN ANIMAL MODEL OF OBESITY & CRAVING USING SKNY-1 REDUCED BODY WEIGHT BY APPROXIMATELY 30% AFTER JUST SIX DAYS

  • MIRA PHARMACEUTICALS INC - TREATED ANIMALS WEIGH 10% LESS THAN HEALTHY CONTROLS - SEC FILING

  • MIRA PHARMACEUTICALS: IN UNTREATED OBESE ANIMALS, FAT BUILDUP IN THE LIVER WAS ABOUT 50% HIGHER THAN NORMAL

Source text: [ID:n0001641172-25-017046]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI